Draft guideline for the evaluation of efficacy of ectoparasiticides - general requirements
Draft guideline for the evaluation of efficacy of ectoparasiticides - general requirements
Draft guideline for the evaluation of efficacy of ectoparasiticides - general requirements
Environmental risk assessment for immunological veterinary medicinal products - Scientific guideline
Design of studies to evaluate the safety and efficacy of fish vaccines - Scientific guideline
User safety for immunological veterinary medicinal products - Scientific guideline
Draft guideline on the requirements for combined vaccines and associations of immunological veterinary medicinal products (IVMPs) - Revision 1
Requirements for combined vaccines and associations of immunological veterinary medicinal products (IVMPs) - Scientific guideline
Scientific advice and protocol assistance adopted during the CHMP meeting 8-11 December 2025
Investigation and assessment of cardiovascular safety of anticancer medicinal products
Reflection paper on investigation and assessment of cardiovascular safety of anticancer medicinal products
Opinion/decision on a Paediatric investigation plan (PIP): Kengrexal, cangrelor (tetrasodium), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Surgical and medical procedures, PIP number: EMA/PE/0000239079